Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Izquierdo, Cristina Pascual
68  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) W..:

Rubia, Javier DE LA ; Gómez-Seguí, Inés ; Cid, Joan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429946/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

P1605: IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA IN OLDER ..:

Seguí, Inés Gómez ; Aracil, Eva Frances ; Eva, Mingot-Castellano Maria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430178/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Real-world effectiveness of caplacizumab vs the standard of..:

Izquierdo, Cristina Pascual ; Mingot-Castellano, María Eva ; Fuentes, Ana E. Kerguelen...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792393/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND,..:

Marie Scully ; Jovanna Baptista ; Indranil Bhattacharya...
http://journals.lww.com/10.1097/01.HS9.0000968132.86513.06.  , 2023
Link: https://doi.org/10.1097/..
 
?
5

P1605: IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA IN OLDER ..:

Inés Gómez Seguí ; Eva Frances Aracil ; Mingot-Castellano Maria Eva...
http://journals.lww.com/10.1097/01.HS9.0000973296.92983.5e.  , 2023
Link: https://doi.org/10.1097/..
 
?
6

S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND,..:

Scully, Marie ; Baptista, Jovanna ; Bhattacharya, Indranil...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428421/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Real-world effectiveness of caplacizumab vs the standard of..:

Pascual Izquierdo, Cristina ; Mingot Castellano, María Eva ; Kerguelen Fuentes, Ana E...
2473-9529.  , 2023
Link: http://hdl.handle.net/10..
 
?
8

P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) W..:

Javier DE LA Rubia ; Inés Gómez-Seguí ; Joan Cid...
http://journals.lww.com/10.1097/01.HS9.0000973312.61163.bd.  , 2023
Link: https://doi.org/10.1097/..
 
?
9

Real-world effectiveness of caplacizumab vs the standard of..:

Pascual Izquierdo, Cristina ; Mingot Castellano, María Eva ; Kerguelen Fuentes, Ana E...
Reproducció del document publicat a: https://doi.org/10.1182/bloodadvances.2022008028.  , 2022
Link: http://hdl.handle.net/24..
 
?
10

Incorporating genetic and clinical data into the prediction..:

Mariana Bastos‐Oreiro ; Javier Ortiz ; Virginia Pradillo...
https://doi.org/10.1002/cam4.4280.  , 2021
Link: https://doi.org/10.1002/..
 
?
11

Incorporating genetic and clinical data into the prediction..:

Bastos‐Oreiro, Mariana ; Ortiz, Javier ; Pradillo, Virginia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559493/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Factores biológicos y eficacia clínica de la fotoféresis ex..:

Pascual Izquierdo, Cristina
https://hdl.handle.net/20.500.14352/22721.  , 2017
Link: https://hdl.handle.net/2..
 
?
13

Recommendations for the Clinical Approach to Immune Thrombo..:

María Eva Mingot-Castellano ; Mariana Canaro Hirnyk ; Blanca Sánchez-González...
https://www.mdpi.com/2077-0383/12/20/6422.  , 2023
Link: https://doi.org/10.3390/..
 
?
14

Acute limb ischemia secondary to vaccine-induced inmune thr..:

Fernando García-Boyano ; Clara M. Castro Ávila ; Miguel Arguello-Tomás...
http://www.sciencedirect.com/science/article/pii/S2772687822000642.  , 2022
Link: https://doi.org/10.1016/..
 
?
15

Recommendations on the Management of Patients with Immune T..:

Tomás José González-López ; Abelardo Bárez ; Angel Bernardo-Gutiérrez...
https://doi.org/10.1007/s40121-022-00745-2.  , 2022
Link: https://doi.org/10.1007/..
 
1-15